Typeone Biomaterials is a technological start-up operating in the biomaterials and medical devices sector. The company has as its main activities, the development, production and trading of natural polymers, in particular collagen extracted from animal tissues, from which it makes customized preparations and formulations (suspensions, films, foils, porous matrices, etc.) to be used in the biomedical, cosmetic and pharmaceutical sector, as well as the conception and prototyping of scaffolds for applications in the regenerative medicine. The company profile is completed by activities such as design and construction of pilot plants for the production of medical devices, management of pre-clinical and clinical processes and the support in regulatory and technical writing activities.
Muro Leccese (LE)
Start up capital
The industrial plan of the company involves the enhancement of the facilities and resources to fully become a qualified production reality, and an investment plan in research and development to complete the design and testing of a range of innovative products. With regard to the first point, the company strategy involves a focus on the production and marketing of high TRL products, such as: collagen powders for cosmetic surgery and/or beauty care cosmetic, or collagen-based injections for interstitial cystitis. For the second point, the company has identified some applications or devices of particular interest in the biomedical, pharmaceutical and cosmetic sectors, and it has started to evaluate their development paths and the business opportunities. The plan is to invest significant resources to complete at least phases I and II of the clinical trial. Partnership are also planned with leading companies in the field.